Postmenopausal hormone replacement in the woman with a reproductive risk factor for breast cancer

Maturitas

Volumn 33, Issue 3, 1999, Pages 191-196

  Scheele, F ^a   Burger, C W ^b   Kenemans, P ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Breast cancer; Menarche; Menopause; Risk factor

Indexed keywords

ESTROGEN;

ARTICLE; BREAST CANCER; FEMALE; HORMONE SUBSTITUTION; HUMAN; MENARCHE; MENOPAUSE; NULLIPARA; POSTMENOPAUSE; RISK FACTOR;

BREAST NEOPLASMS; CASE-CONTROL STUDIES; COHORT STUDIES; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; MENARCHE; MENOPAUSE; REPRODUCTIVE HISTORY; RISK FACTORS;

EID: 0032742378     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5122(99)00083-3     Document Type: Article

References (25)

1. Beral V., Bull D., Doll R. et al. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancer. Lancet. 350:1997;1047-1059.
2. Ettinger B., Friedman G.D., Bush T., Quesenberry C.P. Reduced mortality associated with long-term postmenopausal estrogen therapy. Obstet. Gynecol. 87:1996;6-12.
3. Grodstein F., Stampfer M.J., Colditz G.A. et al. Postmenopausal hormone therapy and mortality. New Engl. J. Med. 336:1997;1769-1775.
4. Greenland S., Rothman K.J. Concepts of interaction. Rothman K.J., Greenland S. Modern Epidemiology. 2nd edn:1998;329-342 Lippincott-Raven, Philadelphia.
5. Harris J.R., Lippmann M.E., Veronesi U., Willett W. Breast cancer. New Engl. J. Med. 327:1992;319-328.
6. Kenemans P., Scheele F. Hormone replacement therapy in patients at high risk of developing breast cancer: the use of a combined risk model. Gynecol. Endocrinol. 11(S1):1997;17-22.
7. Brinton L.A., Hoover R., Fraumeni J.F. Menopausal oestrogens and breast cancer risk: an expanded case-control study. Br. J. Cancer. 54:1986;825-832.
8. Colditz G.A., Stampfer M.J., Willett W.C., Hunter D.J., Manson J.E., Hennekens C.H., Rosner B.A., Speizer F.E. Type of postmenopausal hormone use and risk of breast cancer, 12-year follow up of the Nurses' Health Study. Cancer causes and control. 3:1992;433-439.
9. Dupont W.D., Page D.L., Rogers L.W., Parl F.F. Influence of exogenous estrogens, proliferative breast disease and other variables on breast cancer risk. Cancer. 63:1989;948-957.
10. Hoover R., Glass A., Finkle W.D., Azevedo D., Milne K. Conjugated estrogen and breast cancer risk in women. J. N. C. I. 67:1981;815-820.
11. Hulka B.S., Chambless L.E., Deubner D.C., Wilkinson W.E. Breast cancer and estrogen replacement therapy. Am. J. Obstet. Gynecol. 143:1982;638-644.
12. Kaufman D.W., Miller D.R., Rosenberg L. et al. Non-contraceptive estrogen use and risk of breast cancer. J. Am. Med.Assoc. 252:1984;63-67.
13. Kaufman D.W., Palmer J.R., de Mouzon J., Rosenberg L., Stolley P.D., Warshauer M.E., Zauber A.G., Shapiro S. Estrogen replacement therapy and the risk of breast cancer: results from the case control surveillance study. Am. J. Epidmiol. 134:1991;1375-1385.
14. LaVecchia C., Decarli A., Parazzini F., Gentile A., Liberati C., Franceschi S. Non-contraceptive oestrogens and the risk of breast cancer in women. Int. J. Cancer. 38:1986;853-858.
15. LaVecchia C., Negri E., Franceschi S., Favero A., Nanni O., Filiberti R., Conti E., Montella M., Veronesi A., Ferraroni M., Decarli A. Hormone replacement treatment and breast cancer risk: a cooperative Italian study. Br. J. Cancer. 72:1995;244-248.
16. Mills P.K., Beeson W.L., Phillips R.L., Fraser G.E. Prospective study of exogenous hormone use and breast cancer in Seventh-Day Adventists. Cancer. 64:1989;591-597.
17. Newcomb P.A., Longnecker M.P., Storer B.E., Mittendorf R., Baron J., Clapp R.W., Bogdan G., Willett W.C. Long-term hormone replacement therapy and risk of breast cancer in postmenopausal women. Am. J. Epidemiol. 142:1995;788-795.
18. Nomura A.M.Y., Kolonel L.N., Hirohata T., Lee J. The association of replacement estrogens with breast cancer. Int. J. Cancer. 37:1986;49-53.
19. Palmer J.R., Rosenberg L., Clarke E.A., Miller D.R., Shapiro S. Breast cancer risk after estrogen replacement therapy: results from the Toronto breast cancer study. Am. J. Epidemiol. 134:1991;1386-1395.
20. Rohan T.E., McMichael A.J. Non-contraceptive exogenous estrogen therapy and breast cancer. Med. J. Aust. 148:1988;217-221.
21. Stanford J.L., Weiss N.S., Voigt L.F., Daling J.R., Habel L.A., Rossing M.A. Combined estrogen and progestin hormone replacement therapy in relation to risk of breast cancer in middle-aged women. J. Am. Med. Assoc. 274:1995;137-142.
22. Wingo P.A., Layde P.M., Lee N.C., Rubin G., Ory H.W. The risk of breast cancer in postmenopausal women who have used estrogen replacement therapy. J. Am. Med. Assoc. 257:1987;209-215.
23. Yang C.P., Daling J.R., Band P.R., Gallagher R.P., White E., Weiss N.S. Noncontraceptive hormone use and risk of breast cancer. Cancer Causes and Control. 3:1992;475-479.
24. Greenland S. Additive risk versus additive realtive risk models. Epidemiology. 4:1993;32-36.
25. Russo J., Calaf G., Sohi N. et al. Critical steps in breast carcinogenesis. Ann. NY Acad. Sci. 698:1993;1-20.